| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| STOT | 46.31 | 0.03 | +0.05% |
| State Street DoubleLine Short Duration Total Return Tactical ETF (STOT) | |||
| CPSD | 27.23 | N/A | N/A |
| Calamos S&P 500 Structured Alt Protection ETF - December (CPSD) | |||
| ENDW | 34.53 | -0.07 | -0.21% |
| Cambria Endowment Style ETF (ENDW) | |||
| MCDS | 66.09 | -0.52 | -0.78% |
| JPMorgan Fundamental Data Science Mid Core ETF (MCDS) | |||
| AAXJ | 108.12 | -2.24 | -2.03% |
| iShares MSCI All Country Asia ex Japan ETF (AAXJ) | |||
A.I.dvisor tells us that BMED and IBB have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMED and IBB's prices will move in lockstep.
| Ticker / NAME | Correlation To BMED | 1D Price Change % | ||
|---|---|---|---|---|
| BMED | 100% | -1.45% | ||
| IBB - BMED | 5% Poorly correlated | -2.61% | ||
| IXJ - BMED | 3% Poorly correlated | -0.26% | ||
| XLV - BMED | 0% Poorly correlated | -0.27% | ||
| XBI - BMED | -2% Poorly correlated | -3.65% | ||
| VHT - BMED | -3% Poorly correlated | -0.61% | ||
More | ||||
Category Health
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BMED declined for three days, in 216 of 279 cases, the price declined further within the following month. The odds of a continued downward trend are 77%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on BMED as a result. In 69 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for BMED just turned positive on October 15, 2026. Looking at past instances where BMED's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.
Following a +3.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMED advanced for three days, in 226 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.